9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023

NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

[HTML][HTML] 2021 clinical practice guidelines for diabetes mellitus in Korea

KY Hur, MK Moon, JS Park, SK Kim… - Diabetes & …, 2021 - synapse.koreamed.org
Abstract The Committee of Clinical Practice Guidelines of the Korean Diabetes Association
(KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and …

Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study …

MJ Davies, VR Aroda, BS Collins, RA Gabbay… - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association and the European Association for the Study of Diabetes
convened a panel to update the previous consensus statements on the management of …

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the …

MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green… - Diabetologia, 2022 - Springer
Abstract The American Diabetes Association and the European Association for the Study of
Diabetes convened a panel to update the previous consensus statements on the …

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022

American Diabetes Association Professional … - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …

Body weight considerations in the management of type 2 diabetes

CM Apovian, J Okemah, PM O'Neil - Advances in therapy, 2019 - Springer
Obesity is one of the main risk factors for type 2 diabetes (T2D), representing a major
worldwide health crisis. Modest weight-loss (≥ 5% but< 10%) can minimize and reduce …

A review of GLP‐1 receptor agonists: evolution and advancement, through the lens of randomised controlled trials

VR Aroda - Diabetes, Obesity and Metabolism, 2018 - Wiley Online Library
Aims To review the evolution and advancement of GLP‐1 receptor agonist (GLP‐1RA)
therapy, through the lens of randomised controlled trials, from differentiating characteristics …

Efficacy and safety of LixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes inadequately controlled on basal insulin and …

VR Aroda, J Rosenstock, C Wysham, J Unger… - Diabetes …, 2016 - Am Diabetes Assoc
OBJECTIVE This study was conducted to demonstrate the efficacy and safety of LixiLan
(iGlarLixi), a novel, titratable, fixed-ratio combination of insulin glargine (iGlar)(100 units) …

Analysis and reporting of adverse events in randomised controlled trials: a review

R Phillips, L Hazell, O Sauzet, V Cornelius - BMJ open, 2019 - bmjopen.bmj.com
Objective To ascertain contemporary approaches to the collection, reporting and analysis of
adverse events (AEs) in randomised controlled trials (RCTs) with a primary efficacy …

Efficacy and safety of IDegLira versus basal-bolus insulin therapy in patients with type 2 diabetes uncontrolled on metformin and basal insulin: the DUAL VII …

LK Billings, A Doshi, D Gouet, A Oviedo… - Diabetes …, 2018 - Am Diabetes Assoc
OBJECTIVE In patients with uncontrolled type 2 diabetes on basal insulin, prandial insulin
may be initiated. We assessed the efficacy and safety of initiating insulin degludec/liraglutide …